Πλοήγηση ανά Συγγραφέα "Polyzos, S. A."
-
Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappa B ligand levels in women with established osteoporosis treated with teriparatide
Anastasilakis, A. D.; Goulis, D. G.; Polyzos, S. A.; Gerou, S.; Pavlidou, V.; Koukoulis, G.; Avramidis, A. (2008)Objective: The mechanisms regulating the anabolic response of the skeleton to intermittent exogenous parathyroid hormone (PTH) administration are not fully elucidated. The aim of this prospective study was to evaluate the ... -
Associations of Estrogen Receptor Alpha and Beta Gene Polymorphisms with Lipid Levels and Insulin Resistance in Men
Efstathiadou, Z. A.; Sakka, C.; Polyzos, S. A.; Goutou, M.; Stakias, N.; Bargiota, A.; Koukoulis, G. N. (2015)Objective. The association of four single nucleotide polymorphisms in estrogen receptor alpha (ESR1) and beta (ESR2) genes with lipid levels and insulin resistance in men. Design and methods. Lipids, glucose, insulin and ... -
Associations of Estrogen Receptor Alpha and Beta Gene Polymorphisms with Sex Steroid Levels and Body Fat Content in Men
Sakka, C.; Efstathiadou, Z. A.; Polyzos, S. A.; Goutou, M.; Stakias, N.; Koukoulis, G. N. (2012)Objective: Estrogens play an important role in male physiology. We investigated the possible association of four single nucleotide polymorphisms in Estrogen Receptor alpha (ESR1) and Estrogen Receptor beta (ESR2) genes ... -
Endogenous intact PTH is suppressed during teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis
Anastasilakis, A. D.; Polyzos, S. A.; Goulis, D. G.; Slavakis, A.; Efstathiadou, Z.; Kita, M.; Koukoulis, G.; Avramidis, A. (2008)Introduction: Teriparatide (recombinant human PTH 1-34/TPTD) is an osteoanabolic agent available for osteoporosis treatment. The aim of this prospective trial was to evaluate the acute and chronic effects of TPTD in ... -
Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial
Anastasilakis, A. D.; Goulis, D. G.; Polyzos, S. A.; Gerou, S.; Koukoulis, G. N.; Efstathiadou, Z.; Kita, M.; Avramidis, A. (2008)Aims: We aimed to compare the effect of risedronate (RIS) and teriparatide (TPTD) (recombinant human parathyroid hormone 1-34) on bone turnover markers in women with postmenopausal osteoporosis. Methods: Forty-four Caucasian ... -
Oxidative Stress and Reduced Antioxidative Status, along with Endothelial Dysfunction in Acromegaly
Anagnostis, P.; Efstathiadou, Z. A.; Gougoura, S.; Polyzos, S. A.; Karathanasi, E.; Dritsa, P.; Kita, M.; Koukoulis, G. N. (2013)Acromegaly is characterized by high cardiovascular morbidity and mortality. Oxidative stress and endothelial dysfunction are underlying mechanisms of atherosclerosis. The aim of this study was to evaluate the blood redox ... -
Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: A randomized, controlled trial
Anastasilakis, A. D.; Goulis, D. G.; Polyzos, S. A.; Gerou, S.; Koukoulis, G.; Kita, M.; Avramidis, A. (2008)Risedronate and teriparatide have opposite actions on the osteoblast-osteoclast dipole and are expected to influence the RANK/RANKL/ osteoprotegerin (OPG) system. We aimed to evaluate changes in serum OPG and RANKL after ...